RACECADOTRIL INTERMEDIATE

Racecadotril Intermediate

Racecadotril Intermediate

Blog Article

A.R. Life Science Pvt. Ltd.: Leading Manufacturer of Racecadotril Intermediate


A.R. Life Science Pvt. Ltd., based in Hyderabad, India, has established itself as a pioneer in the pharmaceutical industry. With a strong emphasis on quality and innovation, the company specializes in manufacturing high-grade pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Among its standout offerings is the Racecadotril Intermediate with the chemical name Benzyl glycinate 4-methyl benzenesulfonate (CAS No. 1738-76-7).

This blog explores the properties, therapeutic importance, and mechanism of Benzyl glycinate 4-methyl benzenesulfonate, showcasing its crucial role in the synthesis of Racecadotril, a widely used anti-diarrheal medication.



About Benzyl glycinate 4-methylbenzenesulfonate



  • Product Name: Benzyl glycinate 4-methylbenzenesulfonate

  • CAS No.: 1738-76-7

  • Molecular Formula: C16H19NO5S

  • Molecular Weight: 337.39 g/mol

  • MDL No.: MFCD00035425

  • Purity/Specification: 98%

  • Storage Requirements: Keep in a dark, sealed, and dry environment at room temperature.


Chemical and Physical Properties



  • Appearance: White to off-white crystalline solid

  • Solubility: Soluble in organic solvents such as ethanol, methanol, and acetone

  • Boiling Point: Not available

  • Melting Point: Typically ranges between 140°C–150°C


These properties ensure the stability and reactivity of the compound during the synthesis of Racecadotril.

Mechanism and Therapeutic Action


Benzyl glycinate 4-methylbenzenesulfonate is a key intermediate in the production of Racecadotril, an enkephalinase inhibitor. Racecadotril prevents enkephalins' degradation in the intestinal epithelium, thereby reducing the excessive secretion of water and electrolytes into the intestines. This action alleviates symptoms of diarrhea while maintaining normal intestinal motility.

Therapeutic Uses of Racecadotril


Racecadotril, synthesized using intermediates like Benzyl glycinate 4-methyl benzenesulfonate, is widely prescribed for:

  • Acute Diarrhea: Effective in adults and children, reducing the risk of dehydration.

  • Chronic Diarrhea: Beneficial in managing diarrhoea caused by underlying gastrointestinal disorders.


Why A.R. Life Science Pvt. Ltd. Stands Out


1. Uncompromised Quality


A.R. Life Science ensures the production of Benzyl glycinate 4-methylbenzenesulfonate with a high purity of 98%, adhering to international standards.

2. Advanced Manufacturing Facilities


The company utilizes state-of-the-art technology and GMP-certified processes to deliver top-notch pharmaceutical intermediates.

3. Commitment to Innovation


With decades of experience, A.R. Life Science continually invests in R&D to meet the pharmaceutical industry's evolving demands.

4. Sustainability Focus


The company prioritizes environmentally friendly production practices, ensuring minimal ecological impact.

Conclusion


Benzyl glycinate 4-methylbenzenesulfonate (CAS No. 1738-76-7) is an indispensable intermediate for the synthesis of Racecadotril, a medication that significantly improves the quality of life for patients with diarrhea. By producing this high-quality compound, A.R. Life Science Pvt. Ltd. reinforces its position as a trusted leader in the pharmaceutical sector.

With a commitment to quality, innovation, and sustainability, A.R. Life Science continues to contribute to global healthcare, offering superior pharmaceutical intermediates that drive the development of life-saving medications.

Report this page